In April 2024, the Federal Trade Commission announced that it was expanding its campaign against pharmaceutical manufacturers improper or inaccurate listing of patents in the Food and Drug Administrations (FDA) Orange Book, disputing junk patent listings for diabetes, weight loss, asthma, and COPD drugs, including Novo Nordisk Inc.s blockbuster weight-loss drug, Ozempic. If the administration revoked Novos extension, patent protection for semaglutide will expire in 2026 as it is scheduled to do in many other countries
Phentermine can reduce thirst awareness in some individuals
doi: 10.1007/s00125-004-1380-0 27 DruckerDJ
This chemical peel smoothes the appearance of fine lines, wrinkles, roughness, and addresses skin unevenness due to acne scarring or other pigmentary issues
Skin Contact: Wash thoroughly with water and soap